Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Alexion Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

05 Feb 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for ALXN

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

Trading Report for (ALXN). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for ALXN. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

07 Feb 2016 Stock Traders Daily 6 $20.00

ALEXION PHARMACEUTICAL INC (ALXN=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Alexion Pharmaceuticals Inc (ALXN-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 12 $25.00

Value Graph: ALEXION PHARM -- ALXN

05 Feb 2016 Ford Investor Services, Inc. 1 $12.00

Will Alexion Pharmaceuticals, Inc. Deliver Long-Term Returns?

01 Feb 2016 Sadif Analytics Prime 12 $25.00

Validea Guru Analysis Report for ALXN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

29 Jan 2016 Validea 0 $12.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALEXION PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

29 Jan 2016 Jefferson Research 11 $20.00

ALXN.OQ - Event Transcript of Alexion Pharmaceuticals Inc conference call, Jan. 12, 2016 / 2:00PM ET

Edited Event Transcript of ALXN.OQ conference call, Jan. 12, 2016 / 2:00PM ET San Francisco, Jan 12, 2016 (Thomson Stre...

12 Jan 2016 Thomson Reuters StreetEvents 7 $75.00